Pfizer Inc beat Wall Street estimates for quarterly profit and tweaked its earnings forecast for the year on Tuesday, as it reported rising sales of cancer drug Ibrance and pneumonia vaccine Prevnar, pushing shares in the drugmaker higher.
Source:: Reuters – Business News
